financetom
Business
financetom
/
Business
/
Toyota aims for consistent return on equity, finance executive says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Toyota aims for consistent return on equity, finance executive says
Mar 4, 2025 5:33 PM

TOKYO, March 5 (Reuters) - Toyota Motor ( TM ) is

increasingly focusing on return on equity as a performance

measure, talking internally about raising ROE to 20% as one

guideline, a senior finance executive at the Japanese automaker

said during an interview on Monday.

While cautioning that ROE is not a perfect measure, the

executive emphasised consistency over time-bound targets, adding

that Toyota ( TM ) was not looking to formally commit to achieving a

specific level by a certain date.

"What's important isn't just reaching a certain percentage

by a specific time, but maintaining it consistently," said

Masahiro Yamamoto, chief officer of Toyota's ( TM ) Accounting Group.

ROE is a ratio that measures a company's profitability

relative to its shareholders' equity. Toyota's ( TM ) ROE reached 15.6%

for April-December 2024, in line with the 15.8% for the 2023

fiscal year. The metric has increased from 9.0% in fiscal 2022

and 11.5% in the financial year before that.

Toyota ( TM ) has long been working to improve its profit margin by

reducing the cost it takes to produce its vehicles, thereby

lowering the break-even point for its consolidated sales volume.

Speaking before the U.S. imposed 25% tariffs on imports from

Mexico and Canada on Tuesday, Yamamoto said Toyota ( TM ) - which has

assembly plants in both targeted countries - would provide

information about the impact of tariffs once it was able to.

Last month, Toyota ( TM ) said a nearly $14 billion factory in

North Carolina - its 11th U.S. manufacturing plant - was ready

to begin production, with battery shipments for electrified

vehicles including hybrids starting in April.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Roku Exceeds Q1 Earnings Expectations, Provides Upbeat Guidance
Roku Exceeds Q1 Earnings Expectations, Provides Upbeat Guidance
Apr 25, 2024
Roku, Inc. ( ROKU ) reported its first-quarter financial results after the bell Thursday. Here's a look at the highlights.  The Details: Roku ( ROKU ) reported quarterly losses of 35 cents per share, which beat the analyst consensus estimate of losses of 62 cents by 43.55%.  The company reported quarterly sales of $881.5 million, which beat the analyst consensus...
AvalonBay Communities Q1 Core FFO Rises; Q2, 2024 Outlook Set
AvalonBay Communities Q1 Core FFO Rises; Q2, 2024 Outlook Set
Apr 25, 2024
04:55 PM EDT, 04/25/2024 (MT Newswires) -- AvalonBay Communities ( AVB ) reported Q1 core funds from operations Thursday of $2.70 per share, up from $2.57 a year earlier. Analysts surveyed by Capital IQ expected $2.65. The company said it expects Q2 core funds from operations of $2.63 to $2.73 a share. Analysts surveyed by Capital IQ expect $2.71. AvalonBay...
--Delta Air Lines Keeps Quarterly Dividend at $0.10 a Share, Payable June 4 to Shareholders of Record May 14
--Delta Air Lines Keeps Quarterly Dividend at $0.10 a Share, Payable June 4 to Shareholders of Record May 14
Apr 25, 2024
04:59 PM EDT, 04/25/2024 (MT Newswires) -- Price: 49.75, Change: -0.13, Percent Change: -0.26 ...
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Apr 25, 2024
(Reuters) - Cigna ( CI ) plans to make close copies of AbbVie's ( ABBV ) blockbuster arthritis drug Humira available with no out-of-pocket payment to eligible patients in the U.S. using its specialty pharmacy beginning in June, the health insurer said on Thursday. Cigna ( CI ) said it will stock high- and low-concentration biosimilar versions of Humira from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved